Where does Norgen Biotek Corp. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Norgen Biotek Corp. ranks #24,900 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Norgen Biotek Corp. hold?

Norgen Biotek Corp. holds 11 US utility patents granted between 2015 and 2024, spanning 11 technology areas.

What is Norgen Biotek Corp.'s Innovation Score?

Norgen Biotek Corp. has an Innovation Score of 32.5 out of 100 (41st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Norgen Biotek Corp.'s patent grant rate increasing or decreasing?

Norgen Biotek Corp.'s recent grant velocity is +20% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Norgen Biotek Corp.'s patents?

Norgen Biotek Corp.'s patents average 12.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Norgen Biotek Corp. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Norgen Biotek Corp.

Q: What technology areas does Norgen Biotek Corp. focus on?

Norgen Biotek Corp.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 9 patents, ranking #1,126 of 4,144 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 11 granted patents across 11 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Norgen ranks #24,900 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 11 technology areas.

#24,900
of 49,997 US assignees by volume: 41st percentile
by Innovation Score (32.5/100): 12.0
avg claims per patent: +20%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R24900 · Foreign Corporation #24,900 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #24,900/49,997
PHOTO-FINISH Nidec PSA Emotors
CPC-FOCUS C12N · 11 areas
INNOV-THIN 32.5/100
CLAIMS-RICH 12.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +20% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nidec PSA Emotors (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Norgen’s 32.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (26%) Velocity 5.0 pts (15%) Breadth 11.7 pts (36%) Claim depth 7.2 pts (22%)

Qualcomm Incorporated · highest

85
Norgen Biotek · this assignee

33
3D Lighting… · lowest

7

What this shows Norgen's Innovation Score is 32.5/100 (41st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Norgen?

Each dot is one of Norgen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Norgen’s own 12.0 claims/patent is ABOVE the 4.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Norgen vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Norgen's grants concentrate

Norgen Biotek Corp. is a focused PatentsView assignee: 11 CPC subclasses with 81.8% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2020 (2 grants) versus a trough of 1 in 2015. By volume, Norgen sits between Nidec PSA Emotors and Notal Vision Ltd..

Norgen's three-year grant acceleration

Norgen Biotek Corp. shows 3 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nidec PSA Emotors

11
Nikkeikin Alumini…

11
Ningbo Dongchuan…

11
Ningbo Meiying Te…

11
Northeast Institu…

11
Northeast Petrole…

11
Norwood Industries

11
Notal Vision

11
Norgen Biotek ◀

11

What this shows Norgen holds 11 patents at rank #24,897, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Norgen

By rank, the assignees closest to #24,897 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Norgen's primary technology class.

Norgen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 41st percentile higher than 41% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Norgen Biotek Corp. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	9.1%
2016	1	9.1%
2017	1	9.1%
2018	1	9.1%
2019	1	9.1%
2020	2	18.2%
2021	1	9.1%
2023	1	9.1%
2024	2	18.2%

Which technologies does Norgen Biotek Corp. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 9

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 8

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 3

C11D - Detergent COMPOSITIONS; USE OF Single Substances AS DETERGENTS; Soap OR SOAP-MAKING; Resin SOAPS; Recovery OF Glycerol 2

B01D - Separation 2

C09K - Materials FOR Miscellaneous Applications, NOT Provided FOR Elsewhere 1

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 1

A61B - DIAGNOSIS; SURGERY; Identification 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Norgen Biotek Corp.'s patent record in context - here's where to go next.

Norgen Biotek Corp.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 81.8% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #24,900 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Norgen Biotek Corp. against Nidec PSA Emotors, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.